ON TRACH is an international, multicentre, observational study with the aim of characterising the timing and practice of tracheostomy insertion, management, weaning and longer-term outcomes of these patients, in intensive care units internationally. Participating intensive care units (ICU) will recruit all consecutive patients undergoing tracheostomy insertion over a 12 week period, aiming for broad global representation. This will allow identification of variation in care of patients with a tracheostomy in the intensive care and it's origin, to drive improvement and enhance safety and outcomes for patients with a tracheostomy in the future.
Care of the patient with a tracheostomy is a core element of critical care practice. Around 20% of patients admitted to an intensive care unit (ICU) undergo tracheostomy insertion during their stay, typically in the context of prolonged mechanical ventilation and complex rehabilitation needs. Despite its frequent use and ongoing quality improvement initiatives, considerable variation in practice continues to exist and many questions with regards to tracheostomy timing, insertion, management and longer-term outcomes remain. Variation exists not only because of patient characteristics, but also from an organisational perspective with diversity in hospital settings, system demands and governance structures. These inconsistencies lead to deficiencies in care and avoidable harm, increased morbidity and mortality. This is an international multicentre prospective observational study to comprehensively characterise current tracheostomy practice. The study aims to describe the indications, timing, techniques, and management of tracheostomy insertion and care; to evaluate patient-centred outcomes and procedure-related adverse events; and to explore the organisational structures and models of care supporting tracheostomised patients in the ICU and beyond. This will allow us to identify variation in care, it's origin, drive improvement and enhance safety and outcomes for patients with a tracheostomy in the future.
Study Type
OBSERVATIONAL
Enrollment
2,500
Beth Israel Medical Centre
Boston, Massachusetts, United States
University of Michigan Health Ann Arbor
Ann Arbor, Michigan, United States
Nereu Ramos Hospital
Florianópolis, Brazil
Toronto General Hospital
Toronto, Canada
Tata Memorial Hospital
Mumbai, India
Beaumont Hospital
Dublin, Ireland
Mater Misericordiae University Hospital Dublin
Dublin, Ireland
Galway University Hospital
Galway, Ireland
Ospedale Policlinico San Martino Genoa
Genova, Italy
University of Naples Frederico II
Naples, Italy
...and 3 more locations
Successful tracheostomy decannulation
The proportion of patients successfully decannulated from tracheostomy, censored at hospital discharge or 90 days, whichever comes first.
Time frame: 90 days
Time to decannulation
Time to successful decannulation censored at hospital discharge or 90 days, whichever comes first.
Time frame: 90 days
Mortality
Time frame: 90 days
Hospital utilization metrics
Duration of mechanical ventilation, ICU and hospital length of stay
Time frame: 90 days
Return to vocalisation
Measured by time in days to placement of a speaking valve
Time frame: 90 days
Return to oral intake
Measured using the Functional Oral Intake Scale (FOIS) which ranges from level 1 to 7, where level 1 is no oral intake and level 7 is full oral intake with no restrictions.
Time frame: 90 days
Return to mobilisation
Measured using the Intensive Care Mobility Scale which ranges from 1 to 10 with 10 indicating a greater degree of mobility.
Time frame: 90 days
Health related quality of life
Quality of life measured using the EuroQol five-dimensional questionnaire (EQ-5D-5L) with a lower score indicating a better quality of life.
Time frame: 3, 6 and 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.